Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Prostate. 2017 Nov 6;78(2):121–127. doi: 10.1002/pros.23452

Table 1.

Patient Characteristics of all Eligible Patients

N %
AGE 40
 Median, (range) 68 (50, 85)
RACE
 White 36 90%
 Black 2 5%
 Other 2 5%
Zubrod PS
 0–1 40 100%
 2 0 0%
GLEASON SCORE
 <7 3 8%
 7 7 18%
 >7 30 74%
PSA AT ENTRY (ng/ml)
 < 20 ng/mL 11 28%
 ≥ 20 ng/mL 29 72%
Treatment Arm
Arm 1 - cixutumumab + ADT 24 60%
Arm 2 – ADT alone 16 40%